Swiss Re’s CME Group CME Stock Holding History

Swiss Re’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$159K	Buy	722 +662	+1,103%	+$183K	0.01%	162
2026 Q1	$17.7K	Hold	60	–	–	0.11%	143
2025 Q4	$16.4K	Buy	+60	New	+$16.3K	﹤0.01%	157

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Swiss Re's CME Position: Q2 2026 in Review

Swiss Re increased its CME Group (CME) stake by 1,103% in Q2 2026, buying an estimated $183K and bringing the position to 722 shares worth $159K. The position accounts for 0.01% of the portfolio, ranked #162.

Swiss Re first reported a position in CME in Q4 2025 and has held it in 3 quarters since. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Swiss Re held 722 shares of CME Group worth $159K as of Q2 2026.
Swiss Re bought 662 CME Group shares in Q2 2026, an estimated $183K.
CME Group made up 0.01% of Swiss Re's portfolio in Q2 2026, its #162 holding.
Swiss Re first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.